I help bring new cancer and rare disease treatments to patients, guiding projects from early research all the way through clinical trials. Over the years, I’ve worked with a range of therapies – from small molecules and drug‐device combos to CAR-T/TCR-T cells, viral vector-based gene therapies, oncolytic viruses, antibodies, ADCs, and intratumoral delivery. I’ve led cross‐functional teams to move therapies forward, always focusing on practical results. That means picking the right projects, sizing up the competition, and raising the funds needed to keep the most promising programs on track.
SENIOR LEADER IN DRUG DEVELOPMENT & STRATEGIC PORTFOLIO MANAGEMENT
Dmitry Zamoryakhin, MD MBA
I am a drug development leader focused on oncology and rare diseases, advancing innovative therapies from concept to clinic. I shape R&D portfolios, guide clinical and regulatory strategy, perform due diligence, and support fundraising and investor engagement.
Founder & Principal Medical Consultant
LinkedIn profileAreas of expertise
- Advanced Therapies Expertise — CAR-T, Gene Therapies, ADCs & ATMPs
- R&D Portfolio Strategy, Competitive Intelligence & Scientific Due Diligence
- Oncology & Rare Disease Drug Development
- Clinical & Regulatory Strategy
